Lasa Supergenerics
LASA · Pharma > Pharmaceuticals & Drugs · Chairman: Omkar Herlekar · MD: Omkar Herlekar · Listing date: Sept. 22, 2017 · Employees: 194 · Mumbai · http://lasalabs.com

Stock Price vs Company Growth
1d
5.7%
1w
1.1%
1m
10.8%
3m
16.2%
6m
22.0%
1y
64.0%
5y
34.3%
all
28.0%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 9.79 5.7%
8.78
14.1
Company Overview

Sales
95.3 Cr
Growth: 2.5%
Profit after Tax
-44.4 Cr
Growth: 7.3%
Micro Cap
49 Cr
P/S: 0.5x
Industry P/S: 2.5x
Fundamentals

Sales (Cr) ₹ 95.3
Growth 2.5%
EBITDA -0.3%
P/S 0.5x
Dividend 0.0%
P/E -1.4x
Book Value ₹ 9.45
PEG Ratio -0.5x
ROE -67.1%
P/B 1.0x
Shareholding Pattern

Institutions
Promoters
Omkar Pravin Herlekar
64.47 %
Others
Bebi Dharma Padhir
2.82 %
Anil Vishanji Dedhia
1.76 %
Increase    Decrease    No change
Company Profile Detailed

The company is specialises in ‘catalyst chemistry’ and manufactures anthelmintic/ veterinary API products with the largest production capabilities and product categories in IndiaProduct CategoriesVeterinary API ProductsOther API ProductsAnimal Feed IngredientsReagents For Therapeutic Use
Investors (19)
Followers (3)